Press Releases

Europe's only Parallel Trade event returning to Central London next February. Not only will the next annual instalment feature a packed agenda that focuses on expert-led evaluations on…
Read More...

SMi's Pre-Filled Syringes Preliminary Attendee List released which will gather an audience of over 100 senior drug delivery and medical device experts. With 280 plus Industry…
Read More...

As the North American biotech and pharmaceutical industry continues to reflect imminent growth, SMi Group has brought a portfolio of four significant pharmaceutical conferences to the…
Read More...

The 8th in its series, Pharmaceutical Microbiology East Coast, will debut in New Jersey, November 13- 14, 2017. With only three weeks remaining, both the pharmaceutical and specialty…
Read More...

Paediatric Clinical Trials 2018: Exploring the complexities of paediatric drug formulation to help determine clinical endpoints SMi is pleased to present the return of their 12th…
Read More...

SMi Group is proud to announce the return of Europe’s only Parallel Trade event conference, returning to Central London on 6th& 7th February 2018. The meeting will gather 90+ senior…
Read More...

SMi Reports: SMi’s 2nd annual Drug Discovery conference,taking place in London on 21st and 22nd March 2018, will discuss the role of artificial intelligence in drug discovery ‘The…
Read More...

Social Media in the Pharmaceutical Industry will address questions on how to engage patients with an effective social media strategy,look into understanding behavioural and emotional…
Read More...

SMi are thrilled to welcome Dr. Noreen Roth Henig, Chief Medical Officer, ProQR Therapeutics onto the speaker panel RNA Therapeutics 2018! ProQR is dedicated to discovering and…
Read More...

SMi Group are proud to present the 9th Annual RNA Therapeutics conference, taking place on 21st - 22nd February 2018 at Holiday Inn Kensington Forum, London,…
Read More...

Have you seen the complete agenda for the 10th annual Social Media in the Pharmaceutical Industry? Bringing in voices from top pharma companies and social media experts, to educate,…
Read More...

Next January in San Francisco LEAP HR will host a 2 day forum for progressive HR leaders from the world of bio pharma to totally rethink the people strategies needed in this…
Read More...

Transgene and Randox have entered into a collaboration to combine their technologies and develop multifunctional oncolytic immunotherapies. Innovative oncolytic viruses (OVs) resulting…
Read More...

MiMedx Group, Inc., the leading biopharmaceutical company developing and marketing regenerative and therapeutic biologics utilizing human placental tissue allografts and…
Read More...

Ultragenyx Pharmaceutical Inc., a biopharmaceutical company focused on the development of novel products for rare and ultra-rare diseases, and Dimension Therapeutics, Inc. announced…
Read More...

Aytu BioScience, Inc., a specialty life sciences company focused on global commercialization of novel products in the field of urology, announced that the company has entered into a…
Read More...

Natus Medical Incorporated announced that it has entered into a definitive agreement with Integra LifeSciences Holdings Corporation (NASDAQ:IART) under which Natus will acquire certain…
Read More...

Building on decades of innovation in vaccine development and immunization, PATH announced today it has received a $120 million grant from the Bill & Melinda Gates Foundation to…
Read More...

Bioverativ and Bicycle Therapeutics announced a research collaboration focused on the discovery, development and commercialization of innovative therapies for hemophilia and sickle cell…
Read More...

Champions Oncology, a company engaged in the development and sale of advanced technology solutions and products to personalize the development and use of oncology drugs, announced a…
Read More...